INTRODUCTION
Systemic sclerosis (SSc) is a systemic autoimmune disease characterized by generalized microvascular lesions and obliterative arterial vasculopathy 1 . There are variable organ affection in patients with SSc, including left diastolic heart dysfunction, vascular lesion of the kidney (scleroderma renal crisis) and peripheral arterial disease. Lung and skin fibrosis may also coincide with impaired microcirculation [2] [3] [4] [5] [6] . Markers of inflammation such as increased CRP and ESR level, which may signify increased disease activity and unfavorable prognosis. Several studies showed that the level of ESR was significantly higher in patients with diffuse SSc than in those with localized SSc 7, 8 . Neutrophil lymphocyte ratio (NLR) was considered to be a good marker for inflammation. NLR is increased in patients suffering from malignancies, such as colorectal, breast, and lung cancers; cardiovascular disease; and inflammatory disorders, like acute pancreatitis and ulcerative colitis 9 .
For our knowledge, the relationship between SSC and NLR has not been investigated yet.
The aim of this study was to investigate the association of Neutrophil lymphocyte ratio and the presence of different organ manifestations in patients with SSc.
PATIENTS AND METHODS
Twenty five patients (2 males and 23 females) with SSc were included in this study. The patient's data were collected from the rheumatology clinic files. The patient files were investigated retrospectively. Twenty five healthy subjects of matching age and sex were also included as a control group (2 males and 23 females). Patients older than 18 years and diagnosed to have SSC were included in the study, while those who had malignancy, active infection, diabetes mellitus, and liver failure were excluded from the study. All patients had diffuse SSc and fulfilled the criteria proposed by the American College of Rheumatology for SSc 10 . For each patient: pulmonary function tests, echocardiography were performed. Clinical characteristics included the presence of subcutaneous calcinosis, telangiectasia, skin hypo-/ hyperpigmentation and active skin ulcers. Skin thickness was scored according to the modified Rodnan skin thickness score (mRSS) by summing the skin thickness measurements as determined by palpation on a 0-3 scale in 17 body areas (range 0-51) 11, 12 . ESR, CRP, ANA, anti-SCL 70, ACA and rheumatoid factor were also measured. Complete blood count was performed and NLR was found with a mathematical calculation of the ratio of neutrophils with lymphocytes. Internal organ manifestations were recorded according to a standard protocol as previously described 3 . SSc patients having a forced vital capacity (FVC) < 80% of the predicted value underwent high-resolution CT of the lungs for the Original Article assessment of interstitial lung disease. Left ventricular diastolic abnormality, pericarditis and conduction disturbances were also recorded based on ECG and echocardiography results. Severe micro-/ macrovascular involvement was considered in cases with active digital ulcers, amputation due to peripheral scleroderma-related vascular disease, cardiac conduction disturbance/ arrhythmia, left ventricular ejection fraction <50%, PAH or scleroderma renal crisis.
Statistical Analysis
Comparisons between two groups were performed using a two-tailed unpaired Student t test. Data were presented as mean ± standard deviation and range. Correlations were assessed by using the Pearson correlation test. P value less than 0.05 was considered statistically significant. All analyses were performed using SPSS statistical software (SPSS V.16, Inc., Chicago, IL).
RESULTS
The Demographic, laboratory and clinical data of SSc patients and controls were shown in Table (1) . There was a significant increase in CRP and ESR in SSC patients in comparison to controls (P<0.001, 0.001) respectively.
The CBC findings in SSc patients in comparison to controls were shown in Table ( 2). When compared to controls, the Hb level was significantly decreased in SSc patients (P<0.001), while the leukocytes, neutrophils, lymphocytes and NLR were significantly increased (P<0.001 for all).
Furthermore, there was a significant increase in NLR in SSc patients who had digital ulcers, pulmonary hypertension, left ventricle ejection fraction < 50%, interstitial lung disease and vascular involvement ( patient had at least one of the following findings:
PAH, LVEF <50%, conduction disturbance/arrhythmia, active digital ulcers, scleroderma renal crisis, amputation due to severe peripheral arterial disease) in comparison to SSc patients who didn't have those lesions (P<0.001 for all) as shown in Table (3) .
As for some inflammatory markers, NLR showed a significant positive correlation with both CRP and ESR (P <0.001 for both), while it showed a significant negative correlation with serum albumin (P<0.01) as shown in table (4). 
DISCUSSION
SSc is a complicated autoimmune and connective disease, of which the pathogenesis and treatment have not been fully elucidated 13 . Many studies have evaluated the clinical usefulness of Neutrophil lymphocyte ratio as a prognostic factor in many inflammatory disorders as: systemic lupus erythematosis, rheumatoid arthritis, ankylosing spondilitis and many others. After searching the literature, this is the first study showing the relation between NLR and SSc.
The relation between higher levels of NLR and systemic inflammation is not clear yet. Systemic inflammation affects vascular endothelial cells in a deleterious way, through decreasing the production of nitric oxide and prostacyclin, leading to decreased vasodilation and anti-thrombosis. Also, stimulating leukocytes causing increased adherence to the vascular endothelium 14 . Many cytokines, as interleukins (IL-1ra, IL-6, IL-7, IL-8, IL-12) and platelet derived growth factor (PDGF), take a leading role in the occurrence of inflammation and may have an impact on increased NLR 15 . Neutrophil lymphocyte ratio is found to be related to numerous inflammatory disorders. Kaya et al. 16 reported increased NLR to be a sign of severe atherosclerosis, and they suggested using NLR as a good marker for cardiac risk stratification. NLR has been found to be related with coronary atherosclerosis, and it is reported as an independent factor with CRP in predicting undesirable events in the hospital setting after myocardial infarction and unsuccessful attempt at primary percutaneous intervention 17, 18 . Furthermore, NLR has been shown be an marker for subclinical inflammation, and it was reported to be associated with prognosis in coronary artery disease and heart failure 19, 20 . Also in ulcerative colitis patients, studies reported that high levels of NLR were associated with disease activity, and they suggested the use of NLR as a marker for intestinal inflammation 21, 22 . NLR was shown to be an independent predictor of mortality from ChildTurcotte-Pugh (CTP) and Model for End-Stage Liver Disease scores in patients with liver cirrhosis. NLR has a predictive role in overall and cancer-specific surveillance of many malignancies as malignant tumors of: stomach, lung, breast, and kidney [23] [24] [25] . In patients with other inflammatory conditions, like acute pancreatitis and acute appendicitis, and systemic diseases, like hypertension, diabetes mellitus, and chronic renal failure, the levels of NLR were higher than normal 26, 27 . In patients with familial Mediterranean fever Ahsen et al. 28 reported higher NLR levels in those patients when compared with the control group.
This study highlights the importance of NLR in reflection of the extent of inflammation and vascular involvement in SSC patients. When we investigated patients having at least one of the clinically significant macro-and/or microvascular organ manifestations in the form of (PAH, LVEF <50%, conduction disturbance/arrhythmia, active digital ulcers, scleroderma renal crisis or amputation due to severe peripheral arterial disease) we found a significantly higher mean NLR compared with cases without vascular symptoms ( Table 3 ), indicating that NLR may be useful for the identification of patients with widespread vascular involvement. This indicates that neutrophils play an important role in the development of autoimmune responses in SSC patients.
In this study NLR was significantly higher in SSc patients with interstitial lung disease when compared with SSc without lung disease. It has been previously shown that lung disease coincides with microvascular lesions on nailfold capillaroscopy 1, 6 . NLR values also correlated with markers of inflammation (CRP, ESR), and (albumin). And it is known that activity of SSc involves ongoing vascular process and inflammation, therefore NLR may serve as a potential marker for disease activity and disease severity.
Further investigations are required to clarify the role of NLR as a good marker of disease activity in SSc. Furthermore, an increased NLR could be used clinically as a biomarker associated with decreasing LVEF and development of interstitial lung disease, indicating impairment of cardiovascular function and disease progression.
A limitation of the study is the small sample size of the patients group, and studies conducted on larger scale of patients are recommended to clarify the exact role of NLR in disease activity and progression. Another limitation was its retrospective design. Thus, a prospective study is needed to validate our results, and determine the possibility of using NLR as a prognostic tool or a guide for response to treatment, since Coskan et al 9 documented that Neutrophil lymphocyte ratio can be a valuable and reliable tool of disease activity in patients who have started antitumor necrosis factor (TNF) drugs for ankylosing spondylitis.
The strength of this study is the described results of increasing NLR with decreased cardiopulmonary function. Needless to say that estimation of NLR is easily measured, inexpensive and could contribute in monitoring cardiorespiratory involvement in patients with SSc.
Conclusion
There was significant increase in NLR in SSc patients compared with those of the controls. These findings provide evidence for the occurrence of a systemic inflammatory process in SSc, and suggest a potential role for NLR as a biomarker in evaluating patients with SSc.
NLR may serve as a promising marker for inflammation in SSc may be linked to lung involvement, and could contribute in monitoring cardiorespiratory involvement in patients with SSc, and may serve as a potential biomarker for this complication.
Recommendation
Further studies on larger number of patients and correlation with follow up and treatment received, are needed to elucidate the exact role of NLR in SSc patients.
